Eksaminator: Ph.d.-forsvar Odd Lilleng Gammelgaard: Development and evaluation of novel antibody-based targeting strategies of CD73 for cancer treatment

Activity: Examination and external supervisionInternal examination

Period9. Dec 2019
ExamineeOdd Lilleng Gammelgaard